Face the Facts: Breaking down the cost of prescription drugs

Jonathan Karush 4/15/25 Jonathan Karush 4/15/25

Face the Facts: Breaking down the cost of prescription drugs

NBC Connecticut

Read More

Opinion: Why CT must tackle the PBM problem.

Jonathan Karush 2/17/25 Jonathan Karush 2/17/25

Opinion: Why CT must tackle the PBM problem.

CT Mirror

Read More

US FTC finds major pharmacy benefit managers inflated drug prices for $7.3 billion gain

Jonathan Karush 1/15/25 Jonathan Karush 1/15/25

US FTC finds major pharmacy benefit managers inflated drug prices for $7.3 billion gain

Reuters

Read More

Patients Not PBMs Connecticut Formed to Push for Prescription Drug Transparency at the Pharmacy Counter

Jonathan Karush 1/9/25 Jonathan Karush 1/9/25

Patients Not PBMs Connecticut Formed to Push for Prescription Drug Transparency at the Pharmacy Counter

Read More

GoodRx, PBMs accused of suppressing reimbursements to independent pharmacies

Jonathan Karush 11/6/24 Jonathan Karush 11/6/24

GoodRx, PBMs accused of suppressing reimbursements to independent pharmacies

Reuters

Read More

The Powerful Companies Driving Local Drugstores Out of Business

Jonathan Karush 10/19/24 Jonathan Karush 10/19/24

The Powerful Companies Driving Local Drugstores Out of Business

New York Times

Read More

Mail-Order Drugs Were Supposed to Keep Costs Down. It’s Doing the Opposite.

Jonathan Karush 6/27/24 Jonathan Karush 6/27/24

Mail-Order Drugs Were Supposed to Keep Costs Down. It’s Doing the Opposite.

Wall Street Journal

Read More

3Axis Report Scrutinizes PBM Spread Pricing Practice

Jonathan Karush 6/27/24 Jonathan Karush 6/27/24

3Axis Report Scrutinizes PBM Spread Pricing Practice

Managed Healthcare Executive

Read More

The Opaque Industry Secretly Inflating Prices for Prescription Drugs

Jonathan Karush 6/24/24 Jonathan Karush 6/24/24

The Opaque Industry Secretly Inflating Prices for Prescription Drugs

The New York Times

Read More

Why are so many pharmacies closing?

Jonathan Karush 3/11/24 Jonathan Karush 3/11/24

Why are so many pharmacies closing?

Boston Globe

Read More

Congress looking to cut pharmacy benefit manager profits

Jonathan Karush 1/3/24 Jonathan Karush 1/3/24

Congress looking to cut pharmacy benefit manager profits

News Nation

Read More

How Lowering The Price of a Common Asthma Drug Made It Harder to Get

Jonathan Karush 12/29/23 Jonathan Karush 12/29/23

How Lowering The Price of a Common Asthma Drug Made It Harder to Get

Wall Street Journal

Read More

2024 Outlook: Will legislators pass meaningful reforms to PBMs? The jury is still out

Jonathan Karush 12/21/23 Jonathan Karush 12/21/23

2024 Outlook: Will legislators pass meaningful reforms to PBMs? The jury is still out

Fierce Healthcare

Read More

Pharmacy benefit managers: The middlemen who decide what you pay for medications

Jonathan Karush 12/14/23 Jonathan Karush 12/14/23

Pharmacy benefit managers: The middlemen who decide what you pay for medications

WBUR

Read More

Pharmacy benefit managers are engaging in thievery</a>

Jonathan Karush 11/7/23 Jonathan Karush 11/7/23

Pharmacy benefit managers are engaging in thievery

CommonWealth Beacon

Read More

Hawaii accuses top pharmacy benefit managers of illegally driving up prices

Jonathan Karush 10/5/23 Jonathan Karush 10/5/23

Hawaii accuses top pharmacy benefit managers of illegally driving up prices

Reuters

Read More

Generic Drugs Should Be Cheap, but Insurers Are Charging Thousands of Dollars for Them

Jonathan Karush 9/11/23 Jonathan Karush 9/11/23

Generic Drugs Should Be Cheap, but Insurers Are Charging Thousands of Dollars for Them

Wall St. Journal

Read More

Viewpoint: Middlemen are increasing prescription drug costs. The public needs to know.

Jonathan Karush 3/15/23 Jonathan Karush 3/15/23

Viewpoint: Middlemen are increasing prescription drug costs. The public needs to know.

Boston Business Journal

Read More

When a discount isn’t a discount

Jonathan Karush 3/11/23 Jonathan Karush 3/11/23

When a discount isn’t a discount

CommonWealth Beacon

Read More

Wall Street Journal: Congress Investigates How Pharma Middlemen Affect Drug Prices

Jonathan Karush 3/1/23 Jonathan Karush 3/1/23

Wall Street Journal: Congress Investigates How Pharma Middlemen Affect Drug Prices

Wall Street Journal

Read More